SOLOIST-WHF and updated meta-analysis: sodium-glucose co-transporter 2 inhibitors should be initiated in patients hospitalized with worsening heart failure

被引：17
作者：
Docherty, Kieran F. [1 ]
McMurray, John J. V. [1 ]
机构：
[1] Univ Glasgow, BHF Cardiovasc Res Ctr, Glasgow, Lanark, Scotland
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2021年 / 23卷 / 01期
关键词：
D O I：
10.1002/ejhf.2075
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：27 / 30
页数：4
相关论文
共 14 条
  • [11] Evaluation of the effect of sodium-glucose co-transporter 2 inhibition with empagliflozin on morbidity and mortality of patients with chronic heart failure and a reduced ejection fraction: rationale for and design of the EMPEROR-Reduced trial
    Packer, Milton
    Butler, Javed
    Filippatos, Gerasimos S.
    Jamal, Waheed
    Salsali, Afshin
    Schnee, Janet
    Kimura, Karen
    Zeller, Cordula
    George, Jyothis
    Brueckmann, Martina
    Anker, Stefan D.
    Zannad, Faiez
    Perrone, Sergio
    Nicholls, Stephen
    Janssens, Stefan
    Bocchi, Edmar
    Giannetti, Nadia
    Verma, Subodh
    Jian, Zhang
    Spinar, Jindrich
    Seronde, Marie-France
    Boehm, Michael
    Merkely, Bela
    Chopra, Vijay
    Senni, Michele
    Taddei, Stefano
    Tsutsui, Hiroyuki
    Choi, Dong-Ju
    Chuquiure, Eduardo
    La Rocca, Hans Pieter Brunner
    Ponikowski, Piotr
    Gonzalez Juanatey, Jose Ramon
    Squire, Iain
    Januzzi, James
    Pina, Ileana
    Pocock, Stuart J.
    Carson, Peter
    Doehner, Wolfram
    Miller, Alan
    Haas, Markus
    Pehrson, Steen
    Komajda, Michel
    Anand, Inder
    Teerlink, John
    Rabinstein, Alejandro
    Steiner, Thorsten
    Kamel, Hooman
    Tsivgoulis, Georgios
    Lewis, James
    Freston, James
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 (10) : 1270 - 1278
  • [12] Do We Need Clinical Events Committees to Adjudicate End Points?
    Petrie, Mark C.
    McMurray, John J. V.
    [J]. CIRCULATION-HEART FAILURE, 2020, 13 (07) : 132 - 134
  • [13] Applicability of US Food and Drug Administration Labeling for Dapagliflozin to Patients With Heart Failure With Reduced Ejection Fraction in US Clinical Practice The Get With the Guidelines-Heart Failure (GWTG-HF) Registry
    Vaduganathan, Muthiah
    Greene, Stephen J.
    Zhang, Shuaiqi
    Grau-Sepulveda, Maria
    DeVore, Adam D.
    Butler, Javed
    Heidenreich, Paul A.
    Huang, Joanna C.
    Kittleson, Michelle M.
    Joynt Maddox, Karen E.
    McDermott, James J.
    Owens, Anjali Tiku
    Peterson, Pamela N.
    Solomon, Scott D.
    Vardeny, Orly
    Yancy, Clyde W.
    Fonarow, Gregg C.
    [J]. JAMA CARDIOLOGY, 2021, 6 (03) : 267 - 275
  • [14] SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: a meta-analysis of the EMPEROR-Reduced and DAPA-HF trials
    Zannad, Faiez
    Ferreira, Joao Pedro
    Pocock, Stuart J.
    Anker, Stefan D.
    Butler, Javed
    Filippatos, Gerasimos
    Brueckmann, Martina
    Ofstad, Anne Pernille
    Pfarr, Egon
    Jamal, Waheed
    Packer, Milton
    [J]. LANCET, 2020, 396 (10254) : 819 - 829
12